Chronic Diseases and Translational Medicine

自2025年1月1日起，所有投稿和审稿必须遵守生成式人工智能（AI）指南；CDTM采用Wiley关于研究诚信与出版伦理的最佳实践指南——人工智能。 模型中文摘要

From 1st January 2025, all submissions and reviews must adhere to Generative artificial intelligence (AI) guidelines. Note: CDTM adopts Wiley’s Best Practice Guidelines on Research Integrity and Publishing Ethics – Artificial Intelligence

该期刊遵循国际医学期刊编辑委员会（ICMJE）对作者身份的定义，作者身份应基于四项标准：对工作的构思或设计或数据获取、分析、解释作出实质性贡献；起草或批判性修改重要 intellectual 内容；最终批准发表版本；同意对工作的所有方面负责。 模型中文摘要

The journal adheres to the definition of authorship set up by The International Committee of Medical Journal Editors (ICMJE). The ICMJE recommends that authorship be based on the following 4 criteria:i. Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work;ii. Drafting the work or revising it critically for important…

文章必须包含利益冲突声明，披露所有潜在利益冲突，包括与稿件主题相关的具体财务利益、关系和隶属关系；无利益冲突的作者应在披露部分声明无此类利益。 模型中文摘要

Articles are required to include a disclosure statement. The statement should disclose all potential conflicts of interest, including specific financial interests and relationships and affiliations (other than those affiliations listed in the title page of the manuscript) relevant to the subject of their manuscript. Authors without conflicts of interest should include a statement of no such intere…

该期刊遵循出版伦理委员会（COPE）的核心实践，并相应处理研究和出版不端行为案例；使用iThenticate的CrossCheck软件检测投稿稿件中的重叠和相似文本。 模型中文摘要

This journal follows the core practices of the Committee on Publication Ethics (COPE) and handles cases of research and publication misconduct accordingly (https://publicationethics.org/core-practices). Note this journal uses iThenticate’s CrossCheck software to detect instances of overlapping and similar text in submitted manuscripts. Read Wiley'sTop 10 Publishing Ethics Tips for Authors here. Wi…

如包含第三方版权作品的摘录，必须在贡献中注明出处，作者有责任从版权所有者处获得书面复制许可。 模型中文摘要

If excerpts from copyrighted works owned by third parties are included, credit must be shown in the contribution. It is the author’s responsibility to also obtain written permission for reproduction from the copyright owners. For more information visit Wiley’s Copyright Terms & Conditions FAQ at http://exchanges.wiley.com/authors/faqs---copyright-terms--conditions_301.html

该期刊采用双盲同行评审，作者身份对审稿人保密，反之亦然；投稿稿件通常由两名或以上专家评审，编辑根据评审报告作出决定。 模型中文摘要

Chronic Diseases and Translational Medicine uses double-blind peer review, which means the identities of the authors are concealed from the reviewers, and vice versa. Submitted manuscripts will generally be reviewed by two or more experts who will be asked to evaluate whether the manuscript is scientifically sound and coherent, whether it duplicates already published work, and whether or not the m…

该期刊使用iThenticate的CrossCheck软件检测投稿稿件中的重叠和相似文本。 模型中文摘要

Note this journal uses iThenticate’s CrossCheck software to detect instances of overlapping and similar text in submitted manuscripts.

预印本引用格式示例：J. Chae等，"From Homogeneity to Heterogeneity: Refining Stochastic Simulations of Gene Regulation," preprint, bioRxiv, 2024年9月24日。 模型中文摘要

J. Chae, S. Shin, S. Lee, and J. K. Kim, “From Homogeneity to Heterogeneity: Refining Stochastic Simulations of Gene Regulation,” preprint, bioRxiv, September 24, 2024, https://doi.org/10.1101/2024.09.24.614828.

该期刊要求临床试验在公开可访问的数据库中进行前瞻性注册，报告结果的论文应包含临床试验注册号，作者应在摘要末尾注明试验注册名称和注册号。 模型中文摘要

The journal requires that clinical trials are prospectively registered in a publicly accessible database and clinical trial registration numbers should be included in all papers that report their results. Authors are asked to include the name of the trial register and the clinical trial registration number at the end of the abstract. If the trial is not registered, or was registered retrospectivel…